Patel, R., & Lopresti, J. S. (2020). MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play? J Endocr Soc.
Citação norma ChicagoPatel, Reshma, and Jonathan S. Lopresti. "MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is At Play?" J Endocr Soc 2020.
Citação norma MLAPatel, Reshma, and Jonathan S. Lopresti. "MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is At Play?" J Endocr Soc 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.